Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) EPS (Weighted Average and Diluted) (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.53 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 1225.0% to $0.53 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.45 through Dec 2025, up 178.05% year-over-year, with the annual reading at $3.46 for FY2025, 178.46% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.53 at Bristol Myers Squibb, down from $1.08 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.2 in Q1 2025, with the low at -$5.89 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.45, with a median of $0.79 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 1275.0% in 2021, then crashed 650.47% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $1.07 in 2021, then fell by 11.21% to $0.95 in 2022, then dropped by 8.42% to $0.87 in 2023, then plummeted by 95.4% to $0.04 in 2024, then skyrocketed by 1225.0% to $0.53 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.53, $1.08, and $0.64 for Q4 2025, Q3 2025, and Q2 2025 respectively.